Additionally, the administration of vaspin led to significantly smaller adipocytes, reduced expression of IL-6, and increased expression of GLUT4, suggesting that vaspin could potentially be used to increase insulin sensitivity and inhibit obesity. This evidence concerns the gene SLC2A4 and obesity due to melanocortin 4 receptor deficiency.